Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115376) titled 'Study on immunotherapy combined with chemotherapy for local oral cancer in OSF' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Hunan Cancer Hospital
Condition:
local advanced oral cancer in the context of oral submucous fibrosis
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-01
Target Sample Size: Test group:51;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300629
Published by HT Digital Content Services with permission from Health Daily Digest....